Delivery Order SPE2DB20D1109-SPE2DB25FP51G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The Defense Logistics Agency awarded a delivery order valued at $9,459.08 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,057.06 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $17,406.92 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials. This competitively awarded, firm fixed-price contract was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $17,870.71 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 ml vials on August 27, 2025, with completion targeted for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a $7,359.86 delivery order to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price arrangement for pharmaceutical delivery to support federal medical procurement needs. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $25,071.09 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on September 2, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.29 to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials (5 mL quantity) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $25,669.22 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on September 10, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of September 11, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP51GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,967.59 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a single delivery of the pharmaceutical product to support federal medical procurement needs. The performance location is identified as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for military healthcare systems, AmerisourceBergen Drug Corp utilizes this comprehensive IDC vehicle to supply a broad range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare programs globally. The company's portfolio of federal contract awards demonstrates consistent capability in meeting competitive procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/4/25 |